Emivirine
Names | |
---|---|
IUPAC name
1-(ethoxymethyl)-6-(phenylmethyl)-5-propan-2-ylpyrimidine-2,4-dione | |
Identifiers | |
149950-60-7 | |
3D model (Jmol) | Interactive image |
ChEMBL | ChEMBL35033 |
ChemSpider | 58529 |
PubChem | 65013 |
UNII | X87G8IX72O |
| |
| |
Properties | |
C17H22N2O3 | |
Molar mass | 302.36818 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
Emivirine (MKC-442) is a failed experimental agent for the treatment of HIV. It is a non-nucleoside reverse transcriptase inhibitor.[1] While emivirine showed promising antiviral activity in vitro, it failed to show sufficient efficacy in human trials. However it is still notable as an early proof of concept, which led to the discovery of a number of related antiviral drugs.[2]
References
- ↑ https://pubchem.ncbi.nlm.nih.gov/compound/Emivirine
- ↑ Calenbergh SV, Herdewijn P. A heterogeneous collection of novel antiviral pyrimidines. Expert Opinion on Therapeutic Patents 2000; 10(3):289-295. DOI:10.1517/13543776.10.3.289
This article is issued from Wikipedia - version of the 2/19/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.